BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21993424)

  • 21. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.
    Boutron I; Guittet L; Estellat C; Moher D; Hróbjartsson A; Ravaud P
    PLoS Med; 2007 Feb; 4(2):e61. PubMed ID: 17311468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In the dark: the reporting of blinding status in randomized controlled trials.
    Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
    J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The reporting of methods for reducing and detecting bias: an example from the WHO Misoprostol Third Stage of Labour equivalence randomised controlled trial.
    Piaggio G; Elbourne D; Schulz KF; Villar J; Pinol AP; Gülmezoglu AM;
    BMC Med Res Methodol; 2003 Oct; 3():19. PubMed ID: 14525622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective patient blinding during hyperbaric trials.
    Clarke D
    Undersea Hyperb Med; 2009; 36(1):13-7. PubMed ID: 19341123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies should be controlled, randomized, and blinded.
    Parker RA
    Clin Pharmacol Ther; 2009 May; 85(5):461-3. PubMed ID: 19381148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critique of the double-blind clinical trial. Part 1.
    Kiene H
    Altern Ther Health Med; 1996 Jan; 2(1):74-80. PubMed ID: 8795875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DEPERROR: Risks of systematic errors in drug and non-drug randomized clinical trials assessing intervention effects in patients with unipolar depression.
    Krogh J; Hjorthøj CR; Jakobsen JC; Lindschou J; Kessing LV; Nordentoft M; Gluud C
    J Affect Disord; 2015 Jul; 179():121-7. PubMed ID: 25863907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised controlled trials in orthopaedic surgery and traumatology: overview of parameters and pitfalls.
    Soucacos PN; Johnson EO; Babis G
    Injury; 2008 Jun; 39(6):636-42. PubMed ID: 18533154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trial sequential analyses of meta-analyses of complications in laparoscopic vs. small-incision cholecystectomy: more randomized patients are needed.
    Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
    J Clin Epidemiol; 2010 Mar; 63(3):246-56. PubMed ID: 20004553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The number, content, and quality of randomized controlled trials in the prevention and care of injuries.
    Stelfox HT; Goverman J
    J Trauma; 2008 Dec; 65(6):1488-93. PubMed ID: 19077647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of bias in methodology for randomized controlled trials published on implant dentistry.
    Dumbrigue HB; Al-Bayat MI; Ng CC; Wakefield CW
    J Prosthodont; 2006; 15(4):257-63. PubMed ID: 16827739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blinding in pharmaceutical clinical trials: An overview of points to consider.
    Crisp A
    Contemp Clin Trials; 2015 Jul; 43():155-63. PubMed ID: 26044462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do unblinded assessors bias muscle strength outcomes in randomized controlled trials of progressive resistance strength training in older adults?
    Liu CJ; LaValley M; Latham NK
    Am J Phys Med Rehabil; 2011 Mar; 90(3):190-6. PubMed ID: 21173683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bias in clinical intervention research.
    Gluud LL
    Am J Epidemiol; 2006 Mar; 163(6):493-501. PubMed ID: 16443796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials.
    Devereaux PJ; Manns BJ; Ghali WA; Quan H; Lacchetti C; Montori VM; Bhandari M; Guyatt GH
    JAMA; 2001 Apr; 285(15):2000-3. PubMed ID: 11308438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blinding in randomized controlled trials in general and abdominal surgery: protocol for a systematic review and empirical study.
    Probst P; Grummich K; Heger P; Zaschke S; Knebel P; Ulrich A; Büchler MW; Diener MK
    Syst Rev; 2016 Mar; 5():48. PubMed ID: 27012940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definitions of blinding in randomised controlled trials of interventions published in high-impact anaesthesiology journals: a methodological study and survey of authors.
    Penić A; Begić D; Balajić K; Kowalski M; Marušić A; Puljak L
    BMJ Open; 2020 Apr; 10(4):e035168. PubMed ID: 32284390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.